Synthesis and Antimicrobial Activity of Quinoxaline Based 1,2,3-Triazoles

Synthesis and characterization of novel quinoxaline-1,2,3-triazole hybrid heterocyclic derivatives have been carried out, and their antimicrobial activity has been tested. Antibacterial and antifungal studies of the synthesized compounds have demonstrated high to moderate activity against the tested pathogens for most of those. Several products have been determined to be potent antimicrobial agents at concentrations of 75 and 100 µg/mL as compared to the standard drug Gentamicin.